Login / Signup

Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study.

Akihiko AsahinaYukari OkuboAkimichi MoritaYayoi TadaAtsuyuki IgarashiRichard G LangleyDelphine DeherderMizuho MatanoVeerle VanvoordenMaggie WangMamitaro OhtsukiHidemi Nakagawa
Published in: Dermatology and therapy (2023)
NCT03370133.
Keyphrases
  • double blind
  • coronary artery disease
  • atopic dermatitis
  • clinical trial